.png){kind=icon}
.png){kind=icon}
Return
A real-world implementation study of a TDM-guided dalbavancin model for bone and joint infections (101 Dalbatians)
.png){kind=icon}
OA
AI
A
F
A
C
S
L
R
A
M
M
A
D
A
G
A
M
DOI：10.1093/jacamr/dlag127.png)
.png){kind=icon}
Original request for help.png){kind=icon}
Share.png){kind=icon}
Save
Abstract
En 中文
Dalbavancin is increasingly used off-label for chronic Gram-positive bone and joint infections (BJIs) requiring prolonged antimicrobial therapy, but optimal dosing strategies and the role of therapeutic drug monitoring (TDM) remain unclear. We evaluated the real-world implementation of a proactive TDM-guided dalbavancin workflow within an outpatient parenteral antimicrobial therapy (OPAT) programme.
Journal
J
IF:
3.3
Papers:
1.8K
Citations:
2.1K